Clinical results were evaluated 6 months to I4 years after mitral annuloplasty in 89 operative survivors. Before operation, 13 patients were grade 2, 63 grade 3, and I3 grade 4 (N. Y.H.A. classification). After operation all patients were improved symptomatically. Sixty-one patients were grade I, 27 grade 2, and I patient grade 3. Early clinical deterioration occurred in 5 patients, caused by dehiscence of annuloplasty in 3, and by infective endocarditis in 2, within six months of the operation. Progression of mitral valve disease was responsible for late deterioration I to 8 years after mitral annuloplasty in 23 patients. Sixteen needed mitral valve replacement. There were 12 deaths, including 6 after reoperation. Actuarial analysis showed go per cent survival with annuloplasty at 5 years' and 6o per cent at I0 years' follow-up. Late systemic embolism occurred in only 3 cases though anticoagulants were not used.Haemodynamic studies in I4 unselected patients, 5 to II years after annuloplasty, showed significant reduction in pulmonary wedge andpulmonary arterialpressure when compared with the preoperative values.In view of the satisfactory long-term clinical results, as observed in this study, mitral annuloplasty merits consideration in the surgical treatment ofmitral regurgitation.Despite considerable advances over the past decade, the prevailing uncertainty in the long-term prognosis after mitral valve replacement (Ellis, I967; Ross, I972; Behrendt and Austen, I973) underlines the need for reappraisal of other methods of mitral valve surgery. Mitral annuloplasty, for the correction of mitral regurgitation, was introduced before valve replacement became established (Lillehei et al., 1957; Merendino and Bruce, I957) and this institution was one of the centres to pioneer the technique (Wooler et al., I962). The present study was undertaken to assess the clinical and haemodynamic results after mitral annuloplasty, and to evaluate its relative merits in the surgical treatment of mitral regurgitation.
Subjects and methodsThe study group comprised 89 operative survivors of mitral annuloplasty performed between 1957 and I973. There were 75 women and 14 men in the series and their age distribution, ranging from 8 to 66 years (mean 38-4 years), is indicated in Table I. At the time of operation 13 patients were in grade 2, 63 in grade 3, and I3 in